In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis

Current Eye Research

Volumn 35, Issue 3, 2010, Pages 225-229

  Reddy, Ashok Kumar ^a   Garg, Prashant ^b   Babu, K Hari ^a   Gopinathan, Usha ^a   Sharma, Savitri ^a  

^a Hyderabad Eye Research Foundation   (India)

^b L V PRASAD EYE INSTITUTE   (India)

Author keywords

Amikacin; Azithromycin; Clarithromycin; E test; Keratitis; Nontuberculous mycobacteria

Indexed keywords

AMIKACIN; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; GATIFLOXACIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; CORNEA; EPSILOMETER TEST; KERATITIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL;

ANTI-BACTERIAL AGENTS; CORNEAL ULCER; DRUG RESISTANCE, BACTERIAL; EYE INFECTIONS, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INFECTIONS, ATYPICAL;

EID: 77950851997     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713680903502258     Document Type: Article

References (16)

1. Hyon JY, Jo MJ, Hose S, et al. Comparative efficacy of topical gatifloxacin, with ciprofloxacin, amikacin and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis. Arch Ophthalmol 2004;122:1166-1169 (Pubitemid 39031132)
2. Ford JG, Huang AJW, Pflugfelder SC, et al. Nontuberculous mycobacterial keratitis in South Florida. Ophthalmology 1998;105:1652-1658
3. Brown-Elliott BA, Wallace R, Crist CJ, et al. Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrob Agents and Chemother 2002;46:3283-3285
4. Gross HR, Holland GN, Elias SJ, et al. Corneal pharmacokinetics of topical clarithromycin. IOVS 1995;36:965-968
5. Clinical Laboratory Standards Institute.Susceptability testing of mycobacteria, nocardia and other aerobic actinomycetes. Approved standards CLSI (NCCLS) document M24-A. Wayne, PA: CLSI; 2003
6. Brown-Elliot BA, Wallace RJ. Clinical and taxonomic status of pathogenic non pigmented or late pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002;15: 716-746
7. Lalitha P, Rathinam SR, Srinivasan M. Ocular infections due to nontuberculous mycobacteria. Indian J Med Microbiol 2004;22:231-237 (Pubitemid 39409708)
8. Yang SC, Hsueh PR, Lai HC, et al. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents and Chemother 2003;47:1958-1962
9. Shen GH, Wu BD, Wu KM, et al. In vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan. Antimicrob Agents and Chemother 2007;51:1849-1851 (Pubitemid 46744171)
10. Adekambi T, Colson P, Drancourt M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J Clin Microbiol 2003;41:5699-5708 (Pubitemid 37543269)
11. Wallace RJ, Bedsole G, Sumter G, et al. Activity of ciprofloxacin and oflaxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single drug therapy. Antimicrob Agents and Chemother 1990;34:65-70 (Pubitemid 20019965)
12. Khardori N, Nguyen H, Rosenbaum B, et al. In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents. Antimicrob Agents and Chemother 1994;38:134-137 (Pubitemid 24018170)
13. Collins CH, Uttley AH. In vitro susceptibility of mycobacteria to ciprofloxacin. J Antimicrob Chemother 1985; 16:575-580
14. Brown BA, Wallace RJ, Onyi GO, et al. Activity of four macrolides, including clarithromycin against Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium chelonae-like organisms. Antimicrob Agents and Chemother 1992;36:180-184
15. Freitas D, Alvarena L, Sampaio J, et al. An outbreak of Mycobacterium chelonae infection after LASIK. Ophthalmology 2003,110:276-285 (Pubitemid 36184330)
16. Kuehne J, Yu ALT, Holland GN, et al. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin. Am J Ophthalmol 2004;138:547-553 (Pubitemid 39420480)